Gerlinde Karbon

Gerlinde Karbon

Auto-generated profile, based on publicly available information

Gerlinde Karbon

Institute for Developmental Immunology, Biocenter, Medical University of Innsbruck, Innsbruck, Austria

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 December 2021 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
GKGerlinde Karbon
Gerlinde Karbon
MHManuel D. Haschka
Manuel D. Haschka
Hubert HacklHubert Hackl
Hubert Hackl
CSClaudia Soratroi
Claudia Soratroi
LRLourdes Rocamora-Reverte
Lourdes Rocamora-Reverte
AVAndreas Villunger
Andreas Villunger
Breast cancer (BC) treatment frequently involves microtubule-targeting agents (MTAs), such as paclitaxel, that arrest cells in mitosis. Sensitivity to MTAs is defined by a subset of pro- and anti-apoptotic BCL2 family proteins controlling mitochondrial apoptosis. Here, we aimed to determine their prognostic value in primary tumour samples from 92 BC patients. Our analysis identified high NOXA/PMAIP mRNA expression levels as an independent prognostic marker for improved relapse-free survival (RFS) and overall survival (OS) in multivariate analysis in BC patients, independent of their molecular subtype. Analysis of available TCGA datasets of 1060 BC patients confirmed our results and added a clear predictive value of NOXA mRNA levels for patients who received MTA-based therapy. In this TCGA cohort, 122 patients received MTA-treatment and high NOXA mRNA levels correlated with their progression-free interval (PFI) and OS. Our follow-up analyses in a panel of BC cell lines of different molecular subtypes identified NOXA protein expression as a key determinant of paclitaxel sensitivity in triple-negative breast cancer (TNBC) cells. Moreover, we noted highest additive effects between paclitaxel and chemical inhibition of BCLX, but not BCL2 or MCL1, documenting dependence of TNBC cells on BCLX for survival and paclitaxel sensitivity defined by NOXA expression levels.

29 March 2024 in Science Advances
Verified
Journal Article
Open access
VBVincent Z. Braun
Vincent Z. Braun
GKGerlinde Karbon
Gerlinde Karbon
FSFabian Schuler
Fabian Schuler
MSMarina A. Schapfl
Marina A. Schapfl
JWJohannes G. Weiss
Johannes G. Weiss
AVAndreas Villunger
Andreas Villunger
Deregulated centrosome numbers are frequently found in human cancer and can promote malignancies in model organisms. Current research aims to clarify if extra centrosomes are cause or consequence of malignant transformation, and if their biogenesis can be targeted for therapy. Here, we show that oncogene-driven blood cancer is inert to genetic manipulation of centrosome numbers, whereas the formation of DNA damage–induced malignancies is delayed. We provide first evidence that this unexpected phenomenon is connected to extra centrosomes eliciting a pro-death signal engaging the apoptotic machinery. Apoptosis induction requires the PIDDosome multi-protein complex, as it can be abrogated by loss of any of its three components, Caspase-2 , Raidd/Cradd , or Pidd1 . BCL2 overexpression equally blocks cell death, documenting for the first time induction of mitochondrial apoptosis downstream of extra centrosomes. Our findings demonstrate context-dependent effects of centrosome amplification during transformation and ask to adjust current belief that extra centrosomes are intrinsically pro-tumorigenic.

1 September 2017 in International Journal of Systematic and Evolutionary Microbiology
Verified
Journal Article
Open access
MHMartin W. Hahn
Martin W. Hahn
GKGerlinde Karbon
Gerlinde Karbon
UKUlrike Koll
Ulrike Koll
JSJohanna Schmidt
Johanna Schmidt
ELElke Lang
Elke Lang
Strain MWH-Weng1-1T, isolated from an acidic freshwater habitat located in the Wenger Moor, Austria, was characterized by investigating its phenotypic, chemotaxonomic and genomic traits. Phylogenetic analyses based on 16S rRNA gene sequencing placed the strain in the cryptic species complex PnecC within the genus Polynucleobacter . The strain had a genome of 2.04 Mbp with a G+C content of 45.6 mol%. The major fatty acids of the strain were C16 : 1ω7c, C16 : 0 and C18 : 1ω7c. In order to resolve the systematic position of the strain within the species complex PnecC, concatenated partial sequences of eight housekeeping genes were used for phylogenetic analyses. The obtained trees did not place strain MWH-Weng1-1T close to any of the six previously described species within this cryptic species complex. Pairwise whole genome average nucleotide identity comparisons with genome sequences of strains representing the six previously described species of the subcluster resulted throughout in values <78 %, which clearly suggested that strain MWH-Weng1-1T (DSM 24018T=CIP 111099T) represents a novel species. We propose the name Polynucleobacter sphagniphilus sp. nov. and strain MWH-Weng1-1T as the type strain for this new species.

8 March 2023 in International Journal of Cancer
Verified
Journal Article
Open access
CHChiara Herzog
Chiara Herzog
CVCharlotte D. Vavourakis
Charlotte D. Vavourakis
JBJames E. Barrett
James E. Barrett
GKGerlinde Karbon
Gerlinde Karbon
AVAndreas Villunger
Andreas Villunger
MWMartin Widschwendter
Martin Widschwendter
The impact of a pathogen on host disease can only be studied in samples covering the entire spectrum of pathogenesis. Persistent oncogenic human papilloma virus (HPV) infection is the most common cause for cervical cancer. Here, we investigate HPV‐induced host epigenome‐wide changes prior to development of cytological abnormalities. Using cervical sample methylation array data from disease‐free women with or without an oncogenic HPV infection, we develop the WID (Women's cancer risk identification)‐HPV, a signature reflective of changes in the healthy host epigenome related to high‐risk HPV strains (AUC = 0.78, 95% CI: 0.72‐0.85, in nondiseased women). Looking at HPV‐associated changes across disease development, HPV‐infected women with minor cytological alterations (cervical intraepithelial neoplasia grade 1/2, CIN1/2), but surprisingly not those with precancerous changes or invasive cervical cancer (CIN3+), show an increased WID‐HPV index, indicating the WID‐HPV may reflect a successful viral clearance response absent in progression to cancer. Further investigation revealed the WID‐HPV is positively associated with apoptosis (ρ = 0.48;P < .001) and negatively associated with epigenetic replicative age (ρ = −0.43;P < .001). Taken together, our data suggest the WID‐HPV captures a clearance response associated with apoptosis of HPV‐infected cells. This response may be dampened or lost with increased underlying replicative age of infected cells, resulting in progression to cancer.

28 May 2024 in EMBO Reports
Verified
Journal Article
Open access
GKGerlinde Karbon
Gerlinde Karbon
FSFabian Schuler
Fabian Schuler
VBVincent Z Braun
Vincent Z Braun
FEFelix Eichin
Felix Eichin
MHManuel Haschka
Manuel Haschka
AVAndreas Villunger
Andreas Villunger
Interference with microtubule dynamics in mitosis activates the spindle assembly checkpoint (SAC) to prevent chromosome segregation errors. The SAC induces mitotic arrest by inhibiting the anaphase-promoting complex (APC) via the mitotic checkpoint complex (MCC). The MCC component MAD2 neutralizes the critical APC cofactor, CDC20, preventing exit from mitosis. Extended mitotic arrest can promote mitochondrial apoptosis and caspase activation. However, the impact of mitotic cell death on tissue homeostasis in vivo is ill-defined. By conditional MAD2 overexpression, we observe that chronic SAC activation triggers bone marrow aplasia and intestinal atrophy in mice. While myelosuppression can be compensated for, gastrointestinal atrophy is detrimental. Remarkably, deletion of pro-apoptotic Bim/Bcl2l11 prevents gastrointestinal syndrome, while neither loss of Noxa/Pmaip or co-deletion of Bid and Puma/Bbc3 has such a protective effect, identifying BIM as rate-limiting apoptosis effector in mitotic cell death of the gastrointestinal epithelium. In contrast, only overexpression of anti-apoptotic BCL2, but none of the BH3-only protein deficiencies mentioned above, can mitigate myelosuppression. Our findings highlight tissue and cell-type-specific survival dependencies in response to SAC perturbation in vivo.

22 June 2026 in Nucleic Acids Research
Verified
Journal Article
Open access
AKAna Patricia Kutschat
Ana Patricia Kutschat
FFFabian Frommelt
Fabian Frommelt
BSBrianda L Santini
Brianda L Santini
SMSophie Müller
Sophie Müller
PBPaul Batty
Paul Batty
DSDavide Seruggia
Davide Seruggia
Multiple genetic association studies linked variants at ARID5B with predisposition to B-cell–derived acute lymphoblastic leukemia (B-ALL) in children. Still, the molecular function of ARID5B remains largely uncharacterized. Here, we employ a combination of proteomics, genomics, and transcriptomics to describe the molecular mechanisms of ARID5B. We identify that ARID5B interacts with MIER1, C16ORF87, HDAC1, and HDAC2 forming a chromatin repressor complex. By CUT&RUN, we mapped ARID5B binding in active regions of the genome, tethering HDAC1 and HDAC2 to distal regulatory elements and promoters. Genes actively repressed by the ARID5B repressor complex are involved in B-cell proliferation and B-cell–specific signaling. Together, we describe how ARID5B assembles into a repressor complex and regulates B-cell–specific processes. Understanding its molecular mechanism will help elucidating how noncoding germline variants at ARID5B predispose to B-ALL.